University at Albany, State University of New York

Scholars Archive
Biological Sciences Faculty Scholarship

Biological Sciences

2-25-2022

Epitranscriptomic Reprogramming Is Required to Prevent Stress
and Damage from Acetaminophen
Sara Evke
University at Albany, State University of New York

Qishan Li
University at Albany, State University of New York

Juan Andres Melendez
University at Albany, State University of New York

Thomas John Begley
University at Albany, State University of New York

The University at Albany community has made this article openly available.

Please share how this access benefits you.
Follow this and additional works at: https://scholarsarchive.library.albany.edu/biology_fac_scholar

Recommended Citation
Evke, Sara; Li, Qishan; Melendez, Juan Andres; and Begley, Thomas John, "Epitranscriptomic
Reprogramming Is Required to Prevent Stress and Damage from Acetaminophen" (2022). Biological
Sciences Faculty Scholarship. 32.
https://scholarsarchive.library.albany.edu/biology_fac_scholar/32

This work is licensed under a Creative Commons Attribution 4.0 International License.
This Article is brought to you for free and open access by the Biological Sciences at Scholars Archive. It has been
accepted for inclusion in Biological Sciences Faculty Scholarship by an authorized administrator of Scholars
Archive.
Please see Terms of Use. For more information, please contact scholarsarchive@albany.edu.

G C A T
T A C G
G C A T

genes

Article

Epitranscriptomic Reprogramming Is Required to Prevent
Stress and Damage from Acetaminophen
Sara Evke 1,2 , Qishan Lin 2,3,4 , Juan Andres Melendez 1,2 and Thomas John Begley 2,3,4, *
1

2
3
4

*



Citation: Evke, S.; Lin, Q.; Melendez,
J.A.; Begley, T.J. Epitranscriptomic
Reprogramming Is Required to
Prevent Stress and Damage from
Acetaminophen. Genes 2022, 13, 421.
https://doi.org/10.3390/
genes13030421

Nanobioscience Constellation, College of Nanoscale Science and Engineering, SUNY Polytechnic Institute,
Albany, NY 12203, USA; sevke@sarepta.com (S.E.); jmelendez@sunypoly.edu (J.A.M.)
The RNA Institute, University at Albany, Albany, NY 12222, USA; qlin@albany.edu
Department of Biological Sciences, University at Albany, Albany, NY 12222, USA
RNA Epitranscriptomics and Proteomics Resource, University at Albany, Albany, NY 12222, USA
Correspondence: tbegley@albany.edu

Abstract: Epitranscriptomic marks, in the form of enzyme catalyzed RNA modifications, play important gene regulatory roles in response to environmental and physiological conditions. However, little
is known with respect to how acute toxic doses of pharmaceuticals influence the epitranscriptome.
Here we define how acetaminophen (APAP) induces epitranscriptomic reprogramming and how
the writer Alkylation Repair Homolog 8 (Alkbh8) plays a key gene regulatory role in the response.
Alkbh8 modifies tRNA selenocysteine (tRNASec ) to translationally regulate the production of glutathione peroxidases (Gpx’s) and other selenoproteins, with Gpx enzymes known to play protective
roles during APAP toxicity. We demonstrate that APAP increases toxicity and markers of damage,
and decreases selenoprotein levels in Alkbh8 deficient mouse livers, when compared to wildtype.
APAP also promotes large scale reprogramming of many RNA marks comprising the liver tRNA
epitranscriptome including: 5-methoxycarbonylmethyluridine (mcm5 U), isopentenyladenosine (i6 A),
pseudouridine (Ψ), and 1-methyladenosine (m1 A) modifications linked to tRNASec and many other
tRNA’s. Alkbh8 deficiency also leads to wide-spread epitranscriptomic dysregulation in response to
APAP, demonstrating that a single writer defect can promote downstream changes to a large spectrum
of RNA modifications. Our study highlights the importance of RNA modifications and translational
responses to APAP, identifies writers as key modulators of stress responses in vivo and supports the
idea that the epitranscriptome may play important roles in responses to pharmaceuticals.
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1. Introduction
Epitranscriptomic marks in the form of enzyme-catalyzed RNA modifications are
important gene regulatory signals, with defects linked to disrupted gene expression, disease
onset and disease progression [1]. Modifications on mRNA, rRNA, and tRNA have been
shown to be dynamically regulated to allow cells to survive different stressors and adapt
to changes in cellular physiology [2–9]. In addition, the location and levels of specific
RNA modifications have been shown to drive gene expression. tRNAs are the most
heavily modified RNA species, and RNA modifications are critical for regulating tRNA
structure, function, and stability. Writer enzymes can catalyze or add tRNA modifications,
while eraser enzymes can remove modifications and reader enzymes bind and recognize
modifications. Chemical modifications on tRNAs provide regulation of structure and
function, while those occurring in the anticodon loop positions 34 to 37 can regulate
translation and fidelity. The wobble position (34) in the anticodon stem loop of tRNA allows
pairing to occur with more than one nucleoside, allowing for a single tRNA to decode
multiple codons with different 30 nucleosides [10–12]. Wobble position modifications to
uridine (U), cytidine (C), guanosine (G), and adenosine (A) have all been reported and
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can include simple methylations to more elaborate chemical additions, which can regulate
anticodon-codon interactions while preventing translational errors [10,11].
While most mammalian tRNAs have 3 to 17 positions modified [13], the tRNA for
selenocysteine (tRNASec ) is unique because it only has 4 positions modified. tRNASec
modifications and writers include the 5-methoxycarbonylmethyluridine (mcm5 U) and the
ribose-methylated derivatived, 5-methoxycarbonylmethyl-20 -O-methyluridine (mcm5 Um)
at position U34 which are dependent on alkylation repair homolog 8 (Alkbh8) along with
its accessory protein tRNA methyltransferase 112 (Trm112). The isopentenyladenosine (i6 A)
modification at position A37 is catalyzed by tRNA isopentenyltransferase 1 (Trit1) [14]. The
pseudouridine (Ψ) modification at position U55 is catalyzed by pseudouridine synthase
4 (Pus4) also known as TruB pseudouridine synthase family member 1 (Trub1) [15]. The
1-methyladenosine (m1 A) modification at position A58 is catalyzed by the catalytic subunit of tRNA (adenine-N1 -)-methyltransferase 61A (Trmt61A) and RNA binding protein
non-catalytic subunit tRNA (adenine (58)-N(1))-methyltransferase 6 (Trm6) [16]. Alkbh8,
mcm5 U and mcm5 Um have been shown to play a critical role in the translation of selenoproteins [17–21]. Selenoprotein synthesis is orchestrated by interactions between cis
RNA elements and trans proteins and specifically modified tRNA to recode a UGA stop
codon. Thus, the UGA selenocysteine (Sec) codon found within selenoprotein genes works
with Alkbh8-modified tRNA, as well as other factors, to promote the translation of selenoproteins. There are 25 selenoproteins in human systems with rodents having 24, with
glutathione peroxidase 6 (Gpx6) being the discrepant selenoprotein [22]. Some examples of
selenoproteins include glutathione peroxidase (Gpx)1-4, thioredoxin reductases (TrxR) 1-3,
selenoprotein S (SelS), selenoprotein K (Selk), and selenoprotein P (Selp).
Selenoproteins play roles in stress responses, regulating metabolism, immunity, and
in embryonic vitality and development [23–29]. Many selenoproteins serve as antioxidant
enzymes to mitigate damage caused by reactive oxygen species (ROS) [29–37]. A GeneTrap generated mouse deficient in Alkbh8 (Alkbh8Def ) has been used to generate embryonic
fibroblasts (MEFs), and these cells have been used to demonstrate that writer defects promote increased levels of intracellular ROS and DNA damage and reduced selenoprotein
expression [17]. Alkbh8Def MEFs also display a proliferative defect, accelerate senescence
and fail to increase selenoprotein levels in response to hydrogen peroxide (H2 O2 ) [17,38].
Alkbh8Def mice also have increased lung inflammation and a disruption in lung glutathione
levels [36]. Pulmonary exposure of Alkbh8Def mice to naphthalene, the common polyaromatic
hydrocarbon found in mothballs, increased stress markers and lung damage, when compared to their wildtype (WT) counterparts [36]. Overall, these findings demonstrate that the
epitranscriptomic writer Alkbh8 plays a vital role in protection from environmental stressors.
Little is known with respect to how the epitranscriptome responds to pharmaceutical
stress. Acetaminophen (APAP) is one of the most prevalent over the counter drugs due
to its analgesic and antipyretic properties and is consumed regularly by over 60 million
Americans each week. APAP is a safe and effective drug that combats various ailments.
However, in the United States nearly 50% of all cases of acute liver failure are due to an
excessive use of APAP [39]. Gpx proteins have been linked to preventing APAP toxicity by
providing protection from its metabolized forms [40]. The majority of APAP (85–90%) is
acted upon by phase II metabolism where APAP is chemically altered by UDP-glucuronosyl
transferases (Ugt) and sulfotransferases (Sult), and then converted to glucuronidated
and sulfated metabolites that are eliminated in urine. A small amount (~2%) of APAP
is excreted in urine without modification and the remaining is biometabolized by the
cytochrome enzyme, Cyp2e1, which results in the highly reactive, toxic metabolite Nacetyl-para-benzoquinone imine (NAPQI) [41]. Sufficient glutathione (GSH) in hepatocytes
will reduce the reactive NAPQI and promote excretion in the urine. However excessive
amounts of NAPQI can increase oxidative stress, decrease GSH, and promote mitochondrial
dysfunction leading to depletion of adenosine triphosphate (ATP) stores [42].
Selenoproteins have been shown to provide protection from APAP toxicity. Mirochnitchenko et al. demonstrated that glutathione peroxidase injection provided complete
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protection in mice administered an acute toxic dose of APAP [40]. GPX3 overexpressing
cells are more resistant to APAP toxicity than cells whose GPX3 levels were decreased by
siRNA [43]. Human GPX and mouse Gpx proteins are clearly linked to preventing APAP
toxicity. As selenoprotein synthesis and activity are reliant on RNA modifications that
drive selenocysteine utilization, we hypothesized that Alkbh8-regulated epitranscriptomic
marks would be involved in the response to APAP. Here we test the hypothesis that the
epitranscriptomic writer, Alkbh8, protects against APAP toxicity by catalyzing tRNA modifications that regulate the translation of stress response genes. We have phenotypically
characterized liver tissue from both C57BL/6 WT and Alkbh8Def treated mice with either
saline (vehicle control) or APAP under both acute (6 h) and sub-chronic (4 daily injections)
exposure conditions. When challenged with APAP, WT liver tissue showed an increase in
many selenoproteins whereas the Alkbh8Def liver tissues were disrupted in their expression
and show classic hallmarks of stress and damage, including increased expression of the
oxidative stress marker, 8-isoprostane, and liver damage marker, alanine transaminase
(ALT). Transcriptional responses to acute APAP were similar between the genotypes; however, protein level differences were detected, which is indicative of post-transcriptional
changes and translational regulation reflective of epitranscriptomic regulation. After a single dose of APAP, we have discovered that there is significant change in the levels of many
tRNA modifications in response to APAP. Increases in the levels of tRNA modifications
specific to tRNASec and many other tRNA isoacceptors were identified, with dysregulation
of the many APAP dependent marks observed in Alkbh8Def mice. Our study is one of
the first to characterize the roles of epitranscriptomic marks and writers in response to
APAP, and supports the idea that the epitranscriptome adapts to and modifies the effects of
pharmaceuticals.
2. Materials and Methods
2.1. Animal Experiments
Animal studies were carried out in strict accordance with recommendations in the
guide for the Care and Use of Laboratory Animals of the National Institutes of Health.
The protocol was approved by the University at Albany Institutional Animal Care and
Use Committee (Albany, NY, USA), protocol #17-016/#20-014 for breeding and #18-010 for
APAP exposure. Two homozygous strains of mice of the C57BL/6J background were bred,
WT and Alkbh8Def . Wild-type mice were purchased from Taconic Biosciences (Rensselaer,
NY, USA). Alkbh8Def were produced through an insertional mutagenesis approach targeting
the Alkbh8 gene in the parental E14Tg2a.4 129P2 embryonic stem cell line, as previously
described [17]. Alkbh8Def mice were produced using a vector containing a splice acceptor
sequence upstream of a β-geo cassette (β-galactosidase/neomycin phosphotransferase fusion), which was inserted into intron 7 at chromosome position 9:3349468-3359589, creating
a fusion transcript of Alkbh8-β-geo [44]. Multiplex qRT-PCR and relative cycle threshold
analysis (∆∆CT) on genomic DNA derived from tail biopsies were used to determine
animal zygosity for Alkbh8Def , using TaqMan oligonucleosides specific for neomycin (Neo,
target allele) and T-cell receptor delta (Tcrd, endogenous control). Neo forward (50 -CCA
TTC GAC CAC CAA GCG-30 ), Neo reverse p (50 -AAG ACC GGC TTC CAT CCG-30 ),
Neo Probe (50 -FAM AAC ATC GCA TCG AGC GAG CAC GT TAMRA-30 ), Tcrd forward
(50 -CAG ACT GGT TAT CTG CAA AGC AA-30 ), Tcrd reverse (50 -TCT ATG CAA GTT CCA
AAA AAC ATC-30 ), and Tcrd probe (50 -VIC ATT ATA ACG TGC TCC TGG GAC ACC C
TAMRA-30 ) primers were used for genotyping.
For all animal studies, male mice between 8–12 weeks of age were used. Females
were not used, as they have been shown to be less susceptible to APAP liver injury due to
their accelerated recovery of hepatic glutathione (GSH) levels [45]. Mice were sacrificed via
CO2 asphyxiation and in some cases, followed by non-survival vena cava puncture and
necropsy of the liver. Whole blood was allowed to clot for 30 min at 25 ◦ C, and organs were
flash-frozen and placed in −80 ◦ C for storage.
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2.2. APAP Solution Preparation and Intraperitoneal Injection (I.P.)
APAP and Dulbecco’s phosphate buffered saline (PBS) were purchased from SigmaAldrich (St. Louis, MO, USA). A 5 mg/mL (w/v) solution of APAP was made in a 15 mL
conical tube with 100 mL of PBS and 0.5 g of APAP, due to lower solubility property of
APAP, the solution was boiled until dissolved and then cooled to room temperature before
injection. Solutions were made fresh each day. For intraperitoneal injections (I.P.) mice were
first weighed and then placed under 5% isoflurane gas for approximately three minutes.
The mice were then manually restrained, the injection site was wiped with 70% ethanol,
and either saline or 600 mg/kg APAP solution was injected into the intraperitoneal cavity
in the lower left abdominal quadrant using Coviden™ Monoject™ 27g, 12 inch standard
hypodermic needles (Fisher Scientific, Franklin, MA, USA) and sterile 1 mL Coviden™
Monoject™ tuberculin syringes (Fisher Scientific, Franklin, MA, USA). Injections for acute
exposures occurred once and six hours after the exposure mice were sacrificed. For chronic
conditions, injections were administered at the same time daily for four days, every 24 h,
and mice were sacrificed 24 h post last injection. After injection, mice were observed up to
one hour for recovery from anesthesia and to ensure mice were not experiencing any pain
or distress. Mice were further monitored for signs of excess stress and weight loss, with
any mouse losing more than 20% of its body weight sacrificed based on IACUC guidelines.
2.3. Alanine Transaminase (ALT) Assay
The Alanine Transaminase Colorimetric Activity Assay (Catalog no. 700260, Cayman
Chemical, Ann Arbor, MI, USA) was performed following manufacturer’s protocol to
provide an indicator of liver damage. WT and Alkbh8Def were exposed to either saline
or APAP as described above and sacrificed via CO2 asphyxiation. Cardiac puncture was
then performed using Coviden™ Monoject™ 27g, 12 inch standard hypodermic needles
(Fisher Scientific, Hampton, NH, USA) and sterile 1 mL Coviden™ Monoject™ tuberculin
syringes (Fisher Scientific, Hampton, NH, USA) to collect a minimum volume of 200 µL
of blood. Serum from each sample was prepared by allowing the blood to clot at 25 ◦ C
for 30 min. Samples were centrifuged at 2000× g for 15 min at 4 ◦ C and the top serum
layer was collected and stored at −80 ◦ C. Serum samples were processed based on Alanine
Transaminase Colorimetric Activity Assay Kit (catalog no. 700260, Cayman Chemical, Ann
Arbor, MI, USA) instructions, and absorbance was monitored at 340 nm over a period of
10 min at 1-min intervals. Data analysis was performed, and ALT activity was reported
as U/L. Statistical significance was calculated utilizing three biological replicates for each
exposure condition and genotype, with error bars denoting standard error of the mean
and significance determined using Student’s unpaired t-test in GraphPad Prism version 9.0
(GraphPad, San Diego, CA, USA).
2.4. 8-Isoprostane Assay
The 8-isoprostane assay (Catalog no. ab175819, Abcam, Cambridge, MA, USA) was
performed following manufacturer’s protocol. Mice were exposed to either saline or APAP
as described above and sacrificed via CO2 asphyxiation. Then, 1X phosphate buffered
saline (PBS) was injected into the portal vein and hepatic artery, to remove excess blood
and other cellular debris from the liver. Once dissected from the mouse, the livers were
washed in PBS and then stored at −80 ◦ C. Additional reagents that were used included 2N
Sulfuric Acid Stop Solution (Catalog no. DY994, R&D Systems, Minneapolis, MN, USA),
triphenylphosphine (TPP) (Catalog no. T84409-1G, Sigma-Aldrich, St. Louis, MO, USA),
and ethyl acetate (Catalog no. 270989, Sigma-Aldrich, St. Louis, MO, USA). 8-isoprostane
was measured following manufacturer’s protocol with the adjustment for low sample
volume. Livers were weighed and homogenized in a 500 µL solution containing 5 mg
TPP in dH2 O, and then acidified by adding 4 µL of glacial acetic acid to ensure pH was
~4.0. Next, 500 µL of ethyl acetate was added to each sample, vortexed and centrifuged
at 5000 rpm for 5 min to separate the organic phase. The supernatant was collected and
placed in a new conical tube and the previous step was performed one more time. The
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pooled organic phase supernatant was dried using nitrogen gas and then reconstituted in
20 µL 100% ethanol. Samples were further processed according to manufacturer’s protocol
and then used for ELISA measurement and analyzed. Statistical significance was calculated
utilizing three biological replicates for each exposure condition and genotype with error
bars denoting standard error of the mean and significance determined using Student’s
unpaired t-test in GraphPad Prism v9.
2.5. Protein Quantification Assays
Primary antibodies used for quantification were as follows: TrxR1 (catalog no. MAB7428,
R&D Systems, Minneapolis, MN, USA), TrxR2 (catalog no. ab180493, Abcam, Cambridge,
MA, USA), Gpx1 (Catalog no. AF3798, R&D Systems, Minneapolis, MN, USA), Gpx3 (Catalog #AF4199, R&D Systems, Minneapolis, MN, USA), Gpx4 (catalog no. 565320, Novus Biologicals, Centennial, CO, USA), SelS (catalog no. HPA010025, Sigma-Aldrich, St. Louis, MO,
USA), and Gapdh (catalog no. CB1001, Millipore Sigma, Burlington, MA, USA). Liver tissue
was homogenized in 1 mL RIPA Buffer (50 mM Tris-HCl, pH 7.4, with 150 mM NaCl, 1%
TridonX-100, 0.5% sodium deoxycholate, and 0.1% sodium dodecyl sulfate) supplemented
with an EDTA-free phosphatase inhibitor cocktail 2 (catalog no. P5726, Sigma-Aldrich, St.
Louis, MO, USA) and phosphatase inhibitor cocktail 3 (catalog no. P0044, Sigma-Aldrich,
St. Louis, MO, USA). Livers were agitated periodically on ice for 30 min and then spun at
15,000× g for 12 min at 4 ◦ C. The supernatant was then collected, and protein levels were
quantified via Bradford assay (BioRad, Portland, OR, USA) according to manufacturer’s
instructions at a monochromatic wavelength of 595 nm. Proteins were then normalized to
1.5 µg/mL concentration and added to Wes (ProteinSimple, San Jose, CA, USA) protein
analysis plates (catalog no.SM-W004, ProteinSimple, San Jose, CA, USA) and quantified
with Compass for Simple Western v2.1. Primary antibodies of interest were always multiplexed with endogenous Gapdh primary antibody to normalize chemiluminescence area
under the curve. Statistical significance was calculated utilizing three biological replicates
for each exposure condition and genotype, error bars denote standard error mean with
statistical significance determined using Student’s unpaired t-test in GraphPad Prism v9.
2.6. Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
Small RNAs were first isolated from liver tissue using PureLink™ miRNA Isolation
Kit (catalog no. K157001, Invitrogen, Waltham, MA, USA). RNA concentration was then
quantified at The Center for Functional Genomics/University at Albany using an Agilent
Technologies 2100 Bioanalyzer System (Santa Clara, CA, USA) and the respective Bioanalyzer Small RNA reagents (catalog no. 5067-1548, Agilent Technologies, Santa Clara, CA,
USA). Purified small RNA samples were then digested using Nucleoside Digestion Mix
(catalog no. M0649S, New England BioLabs, Beverly, MA, USA). LC-MS/MS measurement of various post-transcriptional modifications were performed on a Waters XEVO
TQ-STM (Waters, Milford, MA, USA) electrospray triple quadrupole mass spectrometer
configured with ACQUITY I class ultra-performance liquid chromatography, as previously
described [46]. The capillary voltage was set at 1.0 kV with extraction cone of 14 V. Nitrogen
flow was maintained at 1000 L/h and desolvation temperature at 500 ◦ C. The cone gas
flow was set to 150 L/h and nebulizer pressure to 7 bars. Each individual nucleoside
modification was characterized by single infusion in a positive mode ionization over an
m/z range of 100–500 amu. Further nucleoside characterization was performed using
Waters software part of Intellistart MS/MS method development program where a ramp
of collision and cone voltages is applied to find optimal collision energy parameters for
the daughter ions. To quantify various RNA modified nucleosides, calibration curves were
prepared for these modified nucleosides including adenosine, cytidine, guanosine, and
uridine. Stable isotope labelled guanosine [13 C][15 N]-G (1 pg/µL) (cat# CNLM-3808-CA-5,
Cambridge Isotope Laboratories, Inc. Tewksbury, MA, USA) was purchased and used as
an internal standard.
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A method to extract peak areas from raw data to allow quantification was developed
using a combination of instrument manufactures’ suites, MassLynx V4.1 and TargetLynx
(Waters, Milford, MA, USA). These methods allowed extraction of information to produce
calibration curves from each RNA modification standard. In addition, these programs were
used to extract the peak areas to be extrapolated on the standard calibration curves for
quantification of RNA modifications. In house Python scripts combined with Originlab
software suite 2017 (OriginLab Corporation, Northampton, MA, USA) was used to quantify
various RNA modifications. Heat maps were generated using MORPHEUS versatile
matrix visualization and analysis software (https://software.broadinstitute.org/morpheus,
accessed on 10 January 2021).
2.7. RNA Next-Generation Sequencing
Total RNA was isolated from liver tissue. Samples were placed in 1 mL of Trizol reagent
(Invitrogen, Waltham, CA, USA), then homogenized with a Tissue-Tearor homogenizer
(BioSpec, Bartlesville, OK, USA). RNA isolation was performed using manufacturer’s
protocol (catalog no. 15596026, Thermo Fisher Scientific, Waltham. MA, USA). Isolated
RNA samples were treated with DNase I, RNase-free (1 U/µL) (catalog no. EN0521, Thermo
Fisher Scientific, Waltham. MA, USA) following manufacturer’s instruction. Samples
were then processed at The Center of Functional Genomics/University at Albany for
differential expression with Poly-A selection and sequenced using an Illumina Nextseq500
(Illumina, Inc., San Diego, CA, USA) at 75 million single-end reads per run. FASTQ files
are available on NCBI Gene Expression Omnibus (GSE169155). Analysis was performed
through bash and differential expression was analyzed using R Studio v1.3.1093 (Team
2020) (Boston, MA, USA). Enhanced volcano plots were created using DESeq2 package [47]
and EnhancedVolcano with a fold change (FC) cutoff of 1.0 and a pCutoff of 0.05. Gene
count plots of epitranscriptomic writers were created using DeSeq2 and ggplot2 packages.
Metascape analysis [48] was performed with upregulated genes of a log2 fold change cut-off
of 2.0 or greater and ensembl ID lists were uploaded, respectively, per comparison condition.
Statistical significance was calculated utilizing three biological replicates for each exposure
condition and genotype, and was determined using student’s unpaired t-test.
3. Results
3.1. Alkbh8Def Mice Show Sensitivity to APAP Toxicity and Dysregulated Selenoprotein
Expression in the Liver
APAP can be bioactivated by a cytochrome P450 enzyme, Cyp2e1, to catalyze the
formation of the reactive metabolite NAPQI (Figure 1A). The response to toxic levels of
APAP (600 mg/kg) was studied in 8–12-week-old C57BL/6 male WT and Alkbh8Def mice.
Stress biomarkers indicative of liver damage and oxidative stress were measured in serum
derived from whole blood and liver tissue, respectively. Alanine aminotransferase (ALT)
levels were significantly higher in Alkbh8Def livers 6 h after injection of APAP, relative to
APAP exposed WT livers (Figure 1B). The lipid peroxidation product 8-isoprostane is a
in vivo biomarker of oxidative stress [49]. For both saline and 6 h APAP exposure conditions
for Alkbh8Def liver tissue there was a slight increase in 8-isoprostane levels compared to WT
samples (Figure 1C), but it did not reach a significant level (p = 0.33). Glutathione peroxidase
3 (Gpx3) is an extracellular antioxidant enzyme that aids in scavenging hydrogen peroxide
as well as other hydroperoxides [50]. In response to APAP, there is a significant increase
(p = 0.02) in Gpx3 expression in WT compared to its saline control, and this increased
response was not observed in Alkbh8Def liver tissue (Figure 1D).
Daily injections over 4 days were used to study chronic APAP use in the WT and
Alkbh8Def mice. ALT (p = 0.004) and 8-isprostane levels (p = 0.0001) were measured and
found to be significantly increased in the Alkbh8Def mice after APAP injection compared
to WT APAP (Figure 1E,F). Gpx3 expression levels in WT and Alkbh8Def livers were also
significantly (p = 0.02) different after 4 days of APAP exposure (Figure 1G). Similar to 6 h
data, there was an APAP-induced increase in Gpx3 in WT livers, which was not observed
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3.2. Next-Generation Sequencing Analysis Reveals Similar Transcriptional Responses to a Single
Dose of APAP between WT and Alkbh8Def Livers
We next analyzed gene expression using mRNA-seq of livers from saline and APAPinjected mice. Differential transcript expression was first visualized using enhanced volcano
plots, with a padj. values ≤ 0.05, from studies using a single injection of APAP (6 h). WT
APAP vs. WT saline (Figure 2A) and Alkbh8Def APAP vs. Alkbh8Def saline (Figure 2C) both
show an extensive change in gene expression, with many transcripts significantly increased
in response to APAP. These changes can be due to increased gene expression or decreased
mRNA turnover. Enrichment of biological pathways in significantly up-regulated genes
(log2 fold change > 2.0 and padj. values ≤ 0.05) demonstrated that the following similar
pathways were up-regulated in both WT (Figure 2B) and Alkbh8Def (Figure 2D) livers;
MAPK signaling pathway, positive regulation of cell death, fat cell differentiation, osteoclast
differentiation, response to growth factor, and regulation of neuron death. In general, both
genotypes regulate groups of transcripts linked to stress responses. A comparison of
mRNA seq results (Figure 3A) further supports the idea that the transcriptional response to
APAP is very similar in WT and Alkbh8Def livers, where only 202 out of 55,487 measured
transcripts were significantly different (p < 0.05) between the two genotypes. Transcriptional
upregulated genes that had the largest significant difference in fold change include: odorant
binding protein 2A (Obp2a), which aids in binding and transporting molecules with high
affinity for aldehydes and large fatty acids [51], transmembrane protein 267 (Tmeme267),
which present reported function involves protein binding [52], and a member of the MYC
Proto-Oncogene (myc) family that is highly expressed in the brain (Bmyc) and functions as
a transcriptional regulator. We also report similar gene transcript profiles when comparing
WT and Alkbh8Def under saline control conditions (Suplemental Figure S1). The similarities
in the transcriptional responses to APAP between the two genotypes was expected, as
Alkbh8, along with its accessory protein Trm112, post transcriptionally regulate gene
expression by modifying tRNASec (Figure 3B–D) and other tRNAs. Alkbh8 can modify
tRNASec , which is used in stop codon recoding, to drive the translation of 24 selenocysteine
containing proteins in the Mus musculus genome (Figure 3D). Other regulatory components
tied to stop codon recoding include the cis Sec insertion sequence (SECIS), a stem-loop
structure located in coding regions and in 30 UTRs of eukaryotic genes [53].
3.3. The Epitranscriptome Is Extensively Regulated in Response to APAP and Disrupted in
Alkbh8Def Livers
We next analyzed for differences in post transcriptional regulation by quantifying
epitranscriptomic marks in RNA from WT and Alkbh8Def livers. We used LC-MS/MS based
approaches to analyze RNA modification levels in our purified small RNA samples. We
note that the tRNA pool we analyzed has all isoacceptors and we did not analyze RNA
modifications on specific tRNAs. It is interesting that tRNASec possesses four different modifications (Figure 4A) that are catalyzed by either Alkbh8 (mcm5 U), Trmt61A/Trm6 (m1 A),
Pus4 (Ψ), and Trit1 (i6 A), and all four RNA modifications (mcm5 U, m1 A, Ψ, i6 A) are increased in WT livers in response to APAP with these increases absent in Alkbh8Def livers
(Figure 4B). The APAP induced increases in mcm5 U, m1 A, Ψ, and i6 A could be due to
increases throughout the pool of all tRNA isoacceptors, or could be due to increases on
specific isoacceptors, with future studies needed to specifically determine. WT livers had
significantly increased the concentration of the m1 A modification from 55.51 pg/µL to
85.54 pg/µL, whereas the Alkbh8Def livers showed a decreased concentration from saline of
49.94 pg/µL to 38.48 pg/µL after APAP exposure. Similarly, Ψ was increased in WT saline
(49.12 pg/µL) to WT APAP (60.76 pg/µL) conditions and showed a decreased concentration in Alkbh8Def saline (51.10 pg/µL) when compared to Alkbh8Def APAP (35.71 pg/µL)
exposed liver tissue. The i6 A modification was also dysregulated in the Alkbh8Def mice,
where we measured a decreased concentration of 0.54 pg/µL in saline verse 0.42 pg/µL for
APAP exposure. WT liver tissue had increased i6 A modification from 0.64 pg/µL in saline
conditions to 1.25 pg/µL after APAP exposure. Finally, the Alkbh8 dependent mcm5 U
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modification was measured to have minimal change in concentration in the Alkbh8Def liver
tissue between saline (0.0036 pg/µL) and APAP (0.0035 pg/µL) conditions, unlike the WT
liver tissue where we measured a 10-fold increase from 0.004 pg/µL to 0.045 pg/µL in
saline and APAP conditions, respectively. Using our mRNA-seq data we have observed
that transcript levels for some writers are slightly dysregulated under APAP conditions
in Alkbh8Def relative to WT (Figure 4C). The failure to increase epitranscriptomic marks
in response to APAP in Alkbh8Def liver tissue predicts that selenoproteins levels would
be affected. We quantified the protein levels Gpx1 and TrxR2 levels (Figure 4D), and,
similar to Gpx3 (Figure 1D), Gpx1 and TrxR2 were increased in WT livers exposed to APAP;
this stress induced increase in protein levels was absent in Alkbh8Def livers. Gpx4, TrxR1
and selenoprotein S (SelS) also failed to respond to APAP treatment in Alkbh8Def animals
(Supplemental Figure S2).
We also measured 33 other tRNA modifications using LC-MS/MS and compared their
levels, relative to WT saline, using a heat map (Figure 5A). The WT response to APAP
resulted in the observation of 22 RNA modifications increased, whereas in the Alkbh8Def
livers we have 13 modifications decreased (Table S1). In addition, the Alkbh8Def livers had
17 modifications decreased in saline control conditions, relative to WT saline (Supplemental
Table S1A). Individual bar graphs of representative tRNA modifications from the heat map
show mean values with standard error around the mean in WT and Alkbh8Def liver tissue
under saline and APAP exposure conditions (Figure 5B). Other modifications are shown in
(Supplemental Figure S3). The tRNA modifications that were the most downregulated in
the Alkbh8Def APAP samples were; mnm5 U (−6.4 log2 fold change, p < 0.05) and mcm5 U
(−3.7 log2 fold change, p < 0.05). Our epitranscriptomic data provides strong support for
the idea that a single acute toxic dose of APAP promotes significant changes in many tRNA
modifications on many different tRNA isoacceptors. Below we explore whether chronic
APAP exposure promote changes to the epitranscriptome.
3.4. The Alkbh8 Writer Deficient Mice Respond to Chronic APAP with Altered Gene Expression
and Have Increased Markers of Damage
We analyzed mRNA from mice on the 4th day of daily APAP treatments (Supplemental Figures S4 and S5). mRNA sequencing experiments revealed many differences in gene
regulation between WT and Alkbh8Def in response to APAP. The comparison of mRNA-seq
data from WT APAP vs. WT saline identified significantly upregulated genes (p ≤ 0.05)
in pathways related to response to stillbenoid, inflammatory response and unsaturated
fatty acid metabolic process (Figure 6B). The Alkbh8Def APAP vs. Alkbh8Def Saline mRNAseq comparison shows significantly (p ≤ 0.05) upregulated genes that are enriched for
pathways related to mitotic cell cycle process, cellular response to DNA damage stimulus,
and positive regulation of cell cycle (Figure 6C). A comparison of saline controls between
WT and Alkbh8Def show very few differences in transcript levels at the 4-day time point
(Supplemental Figure S4). However, unlike the single APAP dose, the daily doses of APAP
promoted many differences in gene regulation between WT and the Alkbh8Def liver tissue
(Supplemental Figure S5A). Pathways specific to cell division, regulation of cell cycle process and cellular response to DNA damage stimulus were significantly (p ≤ 0.05) enriched
in Alkbh8Def APAP vs. WT APAP comparison (Supplemental Figure S5B), supporting the
idea that there is more stress and DNA damage in Alkbh8Def livers compared to WT. The
same selenoproteins that were measured for the 6 h timepoint were quantitated after 4 days
of daily doses of APAP in liver tissue. Gpx1 expression in the WT mice show an increase in
the APAP exposure group, and relative to WT the Alkbh8Def liver tissue shows decreased
Gpx1. While Gpx4 was not increased in WT after APAP, there was a significant decrease in
the expression of Gpx4 in the Alkbh8Def liver relative to WT. Both TrxR1 and TrxR2 protein
levels were increased in WT APAP samples in response to saline, which was not observed
in Alkbh8Def livers (Figure 6C, Supplemental Figure S6).
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3.3. The Epitranscriptome Is Extensively Regulated in Response to APAP and Disrupted in
Alkbh8Def Livers
We next analyzed for differences in post transcriptional regulation by quantifying

to Gpx3 (Figure 1D), Gpx1 and TrxR2 were increased in WT livers exposed to APAP; thi
stress induced increase in protein levels was absent in Alkbh8Def livers. Gpx4, TrxR1 an
selenoprotein S (SelS) also failed to respond to APAP treatment in Alkbh8Def animals (Sup
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0.05) and mcm5U (−3.7 log2fold change, p < 0.05). Our epitranscriptomic data provides
strong support for the idea that a single acute toxic dose of APAP promotes significant
changes in many tRNA modifications on many different tRNA isoacceptors. Below we
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disrupted response of many tRNA

modifcaitons under chronic APAP condtions. In response to APAP the WT liver tissue
showed significant increases in six modifications, and decreases in two modifications
relative to WT saline. The Alkbh8Def mice had nine modifications significantly decreased
after APAP exposure and five increased, relative to Alkbh8Def saline. The modification that
had a similar response to acute conditions was m1 A, with WT liver showing increases
after APAP exposure and Alkbh8Def liver showing decreases. Many uridine modifications
were measured to be significantly dysregulated in the Alkbh8Def liver tissue compared to
WT after daily APAP exposure including: m5 U, mcm5 s2 U, mnm5 U, mnm5 s2 U, and s2 U.
It is interesting to note that s2 U was measured to be increased after daily APAP exposure

enriched in Alkbh8Def APAP vs. WT APAP comparison (Supplemental Figure S5B), supporting the idea that there is more stress and DNA damage in Alkbh8Def livers compared
to WT. The same selenoproteins that were measured for the 6 h timepoint were quantitated after 4 days of daily doses of APAP in liver tissue. Gpx1 expression in the WT
mice
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was harvested at day 4 and RNA and protein were purified for analysis. (A,B) Enhanced volcano
plots for mRNA-seq data were generated for each of the comparisons and metascape analysis was
performed for log2 FC > 2.0 and padj. values ≤ 0.05. (A) WT APAP vs. WT Saline and (B) Alkbh8Def
APAP vs. Alkbh8Def Saline. (C) Selenoprotein levels were evaluated using the ProteinSimple WES
system. Statistical significance (N = 3) was determined using an unpaired t-test with (* p < 0.05,
** p < 0.01, and *** p < 0.001).

4. Discussion
Hepatoxic effects of APAP toxicity have been widely reported which include oxidative
stress, impaired mitochondrial function, lipid peroxidation, nuclear DNA fragmentation
and necrotic cell death [54–58]. ROS production from the bioactivation of APAP can
promote DNA and protein damage [41,59–61]. The Alkbh8Def mice were unable to respond
to the same stress load as their WT counterparts, and our work supports the idea that the
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epitranscriptomic writer, Alkbh8, has a protective role against APAP toxicity. The protection
comes at the levels of tRNA modification and translation, with Alkbh8 catalyzing tRNA
modifications and translationally regulating the production of stress response proteins.
Wobble U writers in yeast, mice and humans have previously been shown to play key
roles in responding to stress by enhancing the translation of ROS detoxification, DNA
damage response and metabolic proteins [62–65]. For example, deficiencies in the mcm5 U
writer tRNA methyltransferase 9 (Trm9) in yeast sensitize cells to DNA damaging agents
and disrupt cell cycle transitions, with decreased translation of ribonucleotide reductase
genes driving these phenotypes [7,66]. Knockdown of human ALKBH8 in HEK293 cells
sensitize cells to ionizing radiation and disruption of mouse Alkbh8 sensitizes cells to
the mitochondrial poison rotenone, due in part to the decrease in ROS detoxification
enzymes [17,21]. Further it has been reported that there are increased markers of senescence
in Alkbh8Def MEFs [38], highlighting a role for wobble U in regulating cell states linked
to aging and disease. Notably, dysregulated expression of wobble U writers and their
corresponding enzymes have also been linked to the etiology of cancer [4,67–71]. Wobble
U writers play important translational regulatory roles that protect normal cells and organs
from stress, and our studies highlight that the wobble U writer Alkbh8 helps regulate the
response to APAP toxicity.
4.1. Translational Regulation Is a Key Response to APAP
Protein kinase cascades are well described responses to APAP, as it activates the
c-Jun-N-terminal kinase (JNK) through the sequential protein phosphorylation of mitogenactivated protein kinases (MAPK) [72]. JNK is a critical member of the MAPK family
and considered a control point between physiological and pathological status. The activation of JNK has been shown to be important in biological processes including stress
reaction, cellular differentiation, and apoptosis [72,73]. The activated JNK can translocate
to the mitochondria and binds to an outer membrane protein known as Sab, which is also
phosphorylated. JNK binding to Sab leads to further ROS generation and sustains the
activation of JNK leading to the induction of the mitochondrial permeability transition
(MPT) resulting in the mediation of hepatocyte necrosis [74]. c-Myc is induced by APAP
and encompasses one of the most significant protein networks that are associated with liver
injury [75]. Beyer et al., presented gene ontology analysis of transcripts that significantly
correlate with liver necrosis 6 h post-APAP exposure and the resulting biological pathways
included programmed cell death, response to wounding, and inflammatory response [75].
These biological pathways are upregulated in both genotypes of mice after 6 hr APAP
exposure in our study, when compared to their corresponding saline control. Our transcriptional studies support the idea that both WT and Alkbh8Def mice respond to APAP toxicity
similarly at the mRNA level. The transcriptional data suggests that both genotypes have
similar regulation of transcript production and turn-over.
Our study is unique in that we describe a change in RNA modification regulated
protein expression in response to APAP stress. Members of the Gpx and TrxR selenoprotein
families are known to be critical for signaling and aiding in protection and reduction of
harmful oxidants [17,36,76]. Gpx and TrxR selenoproteins have also been shown to be key
regulators of mitochondrial oxidative stress. Inhibition of these antioxidant enzymes with
Auranofin in non-cancerous human Swan-71 cells resulted in reduction of cell viability,
mitochondrial respiration, and increased oxidative stress. Selenium supplementation was
able to restore Gpx and TrxR selenoprotein activity which subsequently decreased ROS
production and increased cell viability [77]. These and other studies [78,79] confirm the
important role of Gpx and TrxR selenoproteins as key response regulators to mitochondrial oxidant stress. Furthermore, APAP hepatoxicity has been reported to result in the
formation of the potent oxidant peroxynitrite from superoxide and nitric oxide [80] which
was subsequently observed to be predominately generated inside the mitochondria [81].
Therefore, the mitochondria are a significant source of oxidant stress in response to APAP.
Our study demonstrated under non-stressed conditions the expression of selenoproteins
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are, relatively, similar between WT and Alkbh8Def . However, after APAP exposure we
observe differences, with WT increasing expression of selenoproteins and Alkbh8Def having no change or decreased expression in measured selenoproteins. Our identification
of a translational response to APAP, specific to selenoproteins that most likely respond
to mitochondrial stress, highlights the importance of protein synthesis-based responses.
Translational regulation is likely occurring in response to all pharmaceuticals that promote
ROS stress, and studies in cancer models support the idea that translational regulation will
be extended to many types of protein families and include regulation of the 20 standard
amino acids [69].
4.2. RNA Modifications Are Systematically and Globally Re-Programmed in tRNAs in Response to
Toxicants and Now Pharmaceuticals
tRNA modifications have been shown to be a critical part of epitranscriptomic reprogramming in response to stressors, chemicals, and physiological states in many organisms [7,17,62]. Our study highlights that APAP promotes a global reprogramming of
RNA modifications. The tRNA modification, i6 A was elevated in WT in response to APAP
however this response was again disrupted in the Alkbh8Def mice. TRIT1 is responsible
for modifying position 37 in the anticodon loop of tRNASec and other tRNAs. The i6 A
modification is found on various cytoplasmic or mitochondrial tRNA. Cytoplasmic i6 A
modification occurs on tRNASer and tRNASec , and mitochondrial tRNAs, mtRNACys , and
mtRNASer [82]. A reduced expression of Trit1 can contribute to decreased selenoprotein
expression [83], decreased translation of other cytoplasmic proteins and/or decreased
mitochondrial translation, which could be occurring in the writer-deficient livers. The
increase in mcm5 U and other tRNASec related modifications in WT livers in response to
APAP are likely key drivers of selenoprotein synthesis.
After APAP exposure, WT liver responds by increasing m1 A modification levels
and this reprogramming is disrupted in the Alkbh8Def mice. m1 A is present in cytosolic
tRNA species at positions 9, 14, 22, 57, and 58, and, notably, on tRNASec at position 58, as
well as mitochondrial tRNA species at positions 9 and 58 [84]. The addition, the m1 A
modification is written by the catalytic protein Trmt61A and the RNA binding protein
Trmt6 [16], while the eraser enzyme (Alkbh1) demethylates the m1 A modification reverting
it to its unmodified form [85]. The m1 A modification aids in mitochondrial tRNA folding
and ensures correct structure formation. The m1 A58 tRNAs have a differential affinity
for the elongation factor EF1A which delivers the tRNA into the A-site of the ribosome in
protein synthesis [86]. Our data supports the idea that m1 A plays an important translational
role in protein synthesis in response to APAP and the deficiency of Alkbh8 dysregulates the
epitranscriptomic reprogramming. Likely the m1 A deficiency contributes to the decrease in
selenoprotein synthesis, but its decrease could also be globally affecting protein synthesis
in the cytoplasm and mitochondria. In addition, the m1 A decrease could be promoting
tRNA instability, which could account for the wide-spread decrease in RNA modifications
in APAP treated Alkbh8Def livers.
The m3 C modification was also significantly upregulated in WT livers after acute
APAP exposure. The m3 C modification is located at position 32 on various tRNA species
as well as their corresponding isoacceptors including; tRNAArg , tRNAMet , tRNASer , and
tRNAThr and mt-tRNAMet , mt-tRNASer , and mt-tRNAThr [87]. The m3 C modification is
catalyzed by the methyltransferase-like protein 2 and 6 (METTL2 and METTL6) [88] and
human METTL6 has been associated with regulating cellular growth, ribosomal occupancy,
and pluripotency in hepatocellular carcinoma (HCC) [89]. Mettl6 knockout mice displayed
altered metabolic activity via altered glucose homeostasis, changes in metabolic turnover,
and decreased liver weight suggesting the impact Mettl6 has on hepatic growth [89].
It is important to note that m3 C Is not found on tRNASec and its increase after APAP
exposure suggests other proteins could be under translational regulation, in addition to
selenoproteins.
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4.3. Redox and Pharmaceuticals Responses Can Be Regulated by the Epitranscriptome
Oxidative stress is catalyzed by the disruption of redox homeostasis and the subsequent production of ROS. The modifications m6 A, m5 C and their respective modifying
enzymes have been reported in various cellular models showing their protective role.
Mettl3, the writer enzyme of m6 A, has been shown to activate the Nrf2 antioxidant pathway in response to colistin-induced oxidative stress in mouse renal tubular epithelial
cells [90]. Arsenite induced stress in human keratinocytes resulted in increased expression
of other m6 A writers, WTAP and Mettl14, which regulate changes in gene expression [91]
as well as inhibiting p53 activation [91]. Eraser and reader enzymes of m6 A also possess
roles in oxidative stress response. FTO, the eraser enzyme, has implications in mitigating
mitochondrial and lipogenesis-induced ROS in HEK293T and clear cell renal carcinoma
cells [92]. FTO is a member of the Fe (II)- and α-KG-dependent dioxygenase enzyme
family which requires electrons from Fe (II) and α-ketoglutarate to activate a dioxygene
molecule [93]. The dioxygenases use oxygen as an electron acceptor to reduce methylation
and to form formaldehyde and hydrogen peroxide which may suppress the overproduction of oxidative stress [94]. It is suggested that oxidative stress oxidizes Fe (II) to Fe
(III) inhibiting the demethylase activity of eraser enzymes such as FTO [95,96]. However,
overexpression of FTO in hepatocytes and myotubes has been linked to increasing lipogenesis and mitochondrial dysfunction leading to increased oxidative stress [97,98]. Reader
enzymes YTHDF1-3 studies have also been shown to have various roles in recognizing
oxidative stress signaling and promote regulation of antioxidant pathways, in addition to
influencing mRNA stability and translation [99,100]. m5 C writer enzymes have been shown
in HeLa and colon cancer cell lines to upregulate NRF2 and induce cellular senescence upon
oxidative stress exposure [101,102]. Together with our current Alkbh8 study, past studies
highlight the importance of epitranscriptomic marks in response to stress and link mcm5 U,
m1 A, m3 C, m6 A, and m5 C as key signals regulating the response to ROS stress. Together
they highlight there is likely a systems-based reprogramming of the epitranscriptome in
response to stress. The observation that an extensive number of RNA modifications are
dysregulated in the liver of Alkbh8Def mice is likely due to the increased ROS stress or
mitochondrial dysfunction [17,36,38]. Studies in yeast have shown that the tRNA epitranscriptome is extensively re-programmed in response to H2 O2 and other ROS-inducing
agents [6–8]. Similarly, Alkbh8 deficiency has been linked to changes in mitochondrial
physiology [38], which could also be driving the extensive epitranscriptomic reprograming.
5. Conclusions
Our study highlights that APAP promotes global reprogramming of the epitranscriptome and its effects can be in part modulated by a single epitranscriptome writer (Figure 7).
The deficiency of Alkbh8 resulted in increased liver damage and oxidative stress in Alkbh8Def
mice upon APAP exposure, which can be linked to a global disruption of epitranscriptomic
reprogramming, a specific decrease in wobble U modification and the decreased translation
of stress response proteins. A major finding of our study is that pharmaceutical stress
promotes changes to the epitranscriptome and RNA modification enzymes can modulate
outcomes. The efficacy of chemotherapeutics and immunotherapies have also been shown
to be modulated by epitranscriptomic systems. METTL3 expression increases resistance
to the chemotherapeutic agents 5-fluorouracil, gemcitabine, and cisplatin in pancreatic
cancer, through activation of the MAPK signaling pathway [103]. The eraser enzyme, FTO,
promotes melanoma tumorigenesis and resistance to immunotherapy, while decreased
FTO expression increased IFNy-induced tumor cell killing and promoted beneficial PD-1
immunotherapy [104]. Similarly, decreased expression of the eraser ALKBH5 increased the
efficiency of PD-1 therapy in both melanoma and colorectal cancer models by decreasing
immunosuppressive cells [105]. Additionally, wobble U34 modifications catalyzed by
ELP3/CTU1/2 have been shown to drive melanomas that express mutated BRAF, with subsequent resistance to anti-BRAF therapy caused by U34-dependent codon-biased translation
of metabolic proteins [70]. It is important to note that many of the previously published
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studies showing that the efficacy of therapeutics can be modulated by epitranscriptomic
marks were performed using in situ models and focus on agents specific to cancer treatment. Our study presents an in vivo model of how a writer can modulate pharmaceutical
stress resulting from a pain reliever and suggests that epitranscriptomic modulation could
augment other therapeutics. Overexpression of Alkbh8 or increased wobble modifications
in tRNASec could limit APAP toxicity and provide an increased protective role against
Genes 2022, 13, x FOR PEER REVIEW oxidative stress. Notably, selenium supplementation has been shown to promote increased
wobble modification of tRNASec and promote selenoprotein expression [106], and it could
offer an effective epitranscriptomic enhancement strategy to counteract APAP overdose.
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